We are live on
!
Find out more
CPX
Canaan Partners XI Portfolio holdings
AUM
$127M
1-Year Est. Return
217.49%
This Fund
S&P 500
This Quarter
Est. Return
+54.16%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$33.9M
(+33%)
Cap. Flow
-$4.28M
Cap. Flow
% of AUM
-3.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blink Charging
BLNK
|
+$14.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyra Biosciences
TYRA
|
+$4.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.08% |
| 2 | Technology | 34.92% |
| 3 | Industrials | 0.01% |
Similar funds
CF
MF
SAP
S
PIP
VDC
SIM
PC
Canaan Partners XI's Q4 2025 Portfolio in Review
As of Q4 2025, Canaan Partners XI held 4 positions worth $137M, up 33% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Canaan Partners XI withdrew a net $4.28M in Q4 2025, reducing 1 holding. Its largest reduction was Tyra Biosciences, cutting an estimated $4.29M.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 49% a quarter earlier, followed by Technology and Industrials.
Against the trend, Canaan Partners XI opened a new position in Blink Charging worth $6.84K.
- Canaan Partners XI's largest Q4 2025 buy was Blink Charging: 10,260 shares worth $6.84K.
- Canaan Partners XI's biggest Q4 2025 reduction was Tyra Biosciences, cutting an estimated $4.29M.
- Canaan Partners XI's ten largest holdings make up 100% of its $137M portfolio in Q4 2025.
- Canaan Partners XI opened 1 new position and closed 0 in Q4 2025.
- Canaan Partners XI's portfolio value rose 33% quarter-over-quarter to $137M.
Based on Canaan Partners XI's 13F filing for Q4 2025, filed 13 Feb 2026.